US$ 26.50
hers semaglutide safe Drug Information As demand grows for GLP-1
Description
These benefits are now also evident in people with obesity at high CVD risk (or with known vascular disease) but without T2D, as shown by the favorable effects of semaglutide in the Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity (SELECT) clinical trial 36
Excellent care

doi: 10.1111/dom.16489

Severe, persistent abdominal pain (with or without vomiting), signs of gallstones (right upper abdominal pain, jaundice), or signs of dehydration warrant urgent medical assessment
The condition is defined as the presence of fat in more than 5% of liver cells (hepatocytes) on histology, or more than 5% liver fat content on MRI
Individual experiences with appetite suppression vary
